7 / 25
Page 62
conferenceseries
.com
Volume 8
Journal of Biotechnology & Biomaterials
ISSN: 2155-952X
Pharma Biotech 2018
December 10-11, 2018
December 10-11, 2018 | Rome, Italy
23
rd
International Conference on
Pharmaceutical Biotechnology
Evaluation of medicine distribution, regulatory privatisation, social welfare services and liberalisation
Abdeen M Omer
Occupational Health Administration-Ministry of Health, Sudan
T
he strategy of price liberalisation and privatisation had been implemented in Sudan over the last decade and had a positive
result on government deficit. The investment law approved recently has good statements and rules on the above strategy
particularly to pharmacy regulations. Under the pressure of the new privatisation policy, the government introduced radical
changes in the pharmacy regulations to improve the effectiveness of the public pharmacy i.e., resources should be switched
towards areas of need, reducing inequalities and promoting better health conditions. Medicines are financed either through
cost sharing or full private. The role of the private services is significant. A review and reform of financing medicines in Sudan
is given in this article. Also, it highlights the current drug supply system in the public sector, which is currently responsible for
the Central Medical Supplies Public Corporation (CMS). In Sudan, the researchers did not identify any rigorous evaluations or
quantitative studies about the impact of drug regulations on the quality of medicines and how to protect public health against
counterfeit or low quality medicines, although it is practically possible. However, the regulations must be continually evaluated
to ensure the public health and is protected against by marketing high quality medicines rather than commercial interests and
the drug companies are held accountable for their conducts.
abdeenomer2@yahoo.co.ukJ Biotechnol Biomater 2018, Volume 8
DOI: 10.4172/2155-952X-C8-110